IngevityNGVT
NGVT
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
20% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 76
6% more capital invested
Capital invested by funds: $1.41B [Q3] → $1.49B (+$83.1M) [Q4]
1.3% more ownership
Funds ownership: 99.4% [Q3] → 100.7% (+1.3%) [Q4]
3% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 33
2% less funds holding
Funds holding: 260 [Q3] → 255 (-5) [Q4]
32% less call options, than puts
Call options by funds: $77K | Put options by funds: $114K
33% less funds holding in top 10
Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$65
70%
upside
Avg. target
$65
70%
upside
High target
$65
70%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
BMO Capital John McNulty 34% 1-year accuracy 16 / 47 met price target | 70%upside $65 | Outperform Upgraded | 26 Feb 2025 |
Financial journalist opinion
Based on 10 articles about NGVT published over the past 30 days
Positive
Zacks Investment Research
1 week ago
Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock?
NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.

Neutral
Business Wire
1 week ago
Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity today announced that it has filed its definitive proxy statement with the U.S. SEC in connection with its 2025 Annual Meeting.

Negative
Zacks Investment Research
1 week ago
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?

Positive
Zacks Investment Research
2 weeks ago
Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Positive
Zacks Investment Research
3 weeks ago
Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Neutral
Business Wire
3 weeks ago
Ingevity announces appointment of David H. Li as president and CEO
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025.

Positive
Zacks Investment Research
3 weeks ago
Here's What Makes Ingevity Stock a Solid Choice Right Now
NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions.

Neutral
Zacks Investment Research
3 weeks ago
Zacks Industry Outlook Axalta Coating, Ingevity and Flexible Solutions International
Axalta Coating, Ingevity and Flexible Solutions International have been highlighted in this Industry Outlook article.

Positive
Zacks Investment Research
4 weeks ago
5 Stocks With Upgraded Broker Ratings Worth Betting on Now
Brokers have more insights into stocks and the macroeconomic backdrop. One must follow broker rating upgrades to pick stocks like NGVT, STRL, NVDA, PYPL & AAL.

Neutral
Zacks Investment Research
4 weeks ago
3 Chemical Specialty Stocks to Watch Amid Industry Challenges
Soft end-market demand dampens the prospects of the Zacks Chemicals Specialty industry. AXTA, NGVT and FSI are set to gain from strategic actions to navigate the ongoing challenges.

Charts implemented using Lightweight Charts™